Overview

Stivarga Regulatory Post-Marketing Surveillance Study in Korea

Status:
Completed
Trial end date:
2019-05-07
Target enrollment:
Participant gender:
Summary
To investigate and collect post-marketing data on the safety of Stivarga in real world practice in its registered indication(s) as required by Health Authority.
Details
Lead Sponsor:
Bayer